Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: MYG005
MIFTS: 43

Myoglobinuria

Categories: Bone diseases, Genetic diseases, Metabolic diseases, Muscle diseases, Nephrological diseases, Neuronal diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Myoglobinuria

About this section

MalaCards integrated aliases for Myoglobinuria:

Name: Myoglobinuria 12 74 43 15 39 32

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases
Anatomical: Muscle diseases Neuronal diseases Nephrological diseases Bone diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:0080108
MeSH 43 D009212
ICD10 32 R82.1
Sources

Summaries for Myoglobinuria

About this section
Disease Ontology : 12 A myopathy that is characterized by an increased urinary excretion of myoglobin.

MalaCards based summary : Myoglobinuria is related to genetic recurrent myoglobinuria and myoglobinuria, recurrent. An important gene associated with Myoglobinuria is LPIN1 (Lipin 1), and among its related pathways/superpathways are Metabolism and Glycosaminoglycan metabolism. The drugs Acetylcysteine and Anti-Infective Agents have been mentioned in the context of this disorder. Affiliated tissues include kidney, testes and liver, and related phenotypes are Decreased viability after gemcitabine stimulation and homeostasis/metabolism

Wikipedia : 74 Myoglobinuria is the presence of myoglobin in the urine, usually associated with rhabdomyolysis or... more...

Sources

Related Diseases for Myoglobinuria

About this section

Diseases in the Myoglobinuria family:

Myoglobinuria, Autosomal Dominant Myoglobinuria, Acute Recurrent, Autosomal Recessive
Myoglobinuria, Recurrent

Diseases related to Myoglobinuria via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 177)
# Related Disease Score Top Affiliating Genes
1 genetic recurrent myoglobinuria 34.3 MT-CO3 MT-CO1 LPIN1
2 myoglobinuria, recurrent 34.1 PYGM MT-CO1 DMD CPT2 ACADVL
3 glycogen storage disease vii 32.9 PYGM PGAM2 PFKM AMPD1
4 acyl-coa dehydrogenase, very long-chain, deficiency of 32.8 HADH CPT2 ACADVL
5 carnitine palmitoyltransferase ii deficiency, infantile 32.1 PYGM HADH CPT2 AMPD1 ACADVL
6 glycogen storage disease v 31.9 PYGM PHKA1 PGAM2 PFKM MB CPT2
7 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 31.2 PIK3C2A PFKM MB CPT2 ACADVL
8 acute kidney failure 31.1 PIK3C2A MB GPT CPT2
9 gas gangrene 30.5 PIK3C2A MB DMD
10 compartment syndrome 30.4 PIK3C2A MB GPT
11 mitochondrial complex iv deficiency 30.4 PYGM MT-CO3 MT-CO1
12 metabolic myopathy 30.4 PGAM2 MB AMPD1
13 neuroleptic malignant syndrome 30.3 PIK3C2A MB GPT
14 pyomyositis 30.3 PIK3C2A MB
15 mitochondrial metabolism disease 30.3 MT-CYB MT-CO3 MT-CO1 CPT2
16 3-hydroxyacyl-coa dehydrogenase deficiency 30.1 HADH ACADVL
17 kearns-sayre syndrome 30.1 PYGM MT-CYB MT-CO3 MT-CO1
18 lactic acidosis 30.0 MT-CYB MT-CO3 MT-CO1 GPT
19 creatine phosphokinase, elevated serum 30.0 PIK3C2A MB DMD
20 disseminated intravascular coagulation 29.9 PIK3C2A MB GPT
21 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 29.8 MT-CYB MT-CO3 MT-CO1 CPT2 AMPD1
22 respiratory failure 29.7 PIK3C2A GPT DMD CPT2 ACADVL
23 malignant hyperthermia 29.7 PIK3C2A MB GPT DMD CPT2 AMPD1
24 multiple acyl-coa dehydrogenase deficiency 29.5 PYGM HADH CPT2 AMPD1 ACADVL
25 neuromuscular disease 29.3 MB GAPDH DMD AMPD1
26 glycogen storage disease 28.9 PYGM PHKA1 PGAM2 PFKM MB LDHA
27 muscular disease 27.5 PYGM PIK3C2A MT-CYB MT-CO1 MB GPT
28 myoglobinuria, acute recurrent, autosomal recessive 12.7
29 myoglobinuria, autosomal dominant 12.5
30 myopathy with deficiency of iron-sulfur cluster assembly enzyme 11.8
31 carnitine palmitoyltransferase ii deficiency, myopathic, stress-induced 11.8
32 myopathy with lactic acidosis, hereditary 11.7
33 phosphoglycerate kinase 1 deficiency 11.7
34 phosphorylase kinase deficiency 11.7
35 myopathy 11.6
36 glycogen storage disease x 11.5
37 marinesco-sjogren syndrome 11.4
38 congenital cataracts, facial dysmorphism, and neuropathy 11.4
39 fanconi-bickel syndrome 11.1
40 glycogen storage disease, type ixd 11.1
41 brody myopathy 11.1
42 lactate dehydrogenase deficiency 11.1
43 muscular phosphorylase kinase deficiency 11.1
44 kidney disease 10.7
45 muscular dystrophy 10.5
46 pediculus humanus capitis infestation 10.5 MT-CYB MT-CO1
47 sparganosis 10.4 MT-CYB MT-CO1
48 subendocardial myocardial infarction 10.4 PIK3C2A LDHA
49 hemoglobinuria 10.4
50 myiasis 10.4 MT-CYB MT-CO1

Graphical network of the top 20 diseases related to Myoglobinuria:



Diseases related to Myoglobinuria
Sources

Symptoms & Phenotypes for Myoglobinuria

About this section

GenomeRNAi Phenotypes related to Myoglobinuria according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability after gemcitabine stimulation GR00107-A-2 8.8 PFKM PHKA1 PIK3C2A

MGI Mouse Phenotypes related to Myoglobinuria:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.77 ACADVL AMPD1 CPT2 DMD HADH LDHA
2 muscle MP:0005369 9.28 ACADVL AMPD1 DMD LPIN1 MB MT-CO1
Sources

Drugs & Therapeutics for Myoglobinuria

About this section

Drugs for Myoglobinuria (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcysteine Approved, Investigational Phase 2, Phase 3 616-91-1 12035
2 Anti-Infective Agents Phase 2, Phase 3
3 N-monoacetylcystine Phase 2, Phase 3
4 Free Radical Scavengers Phase 2, Phase 3
5 Antiviral Agents Phase 2, Phase 3
6 Respiratory System Agents Phase 2, Phase 3
7 Antioxidants Phase 2, Phase 3
8 Protective Agents Phase 2, Phase 3
9 Antidotes Phase 2, Phase 3
10 Expectorants Phase 2, Phase 3
11
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
12
Bezafibrate Approved, Investigational Phase 2 41859-67-0 39042
13 Tranquilizing Agents Phase 2
14 Neurotransmitter Agents Phase 2
15 Psychotropic Drugs Phase 2
16 GABA Agents Phase 2
17 Anticonvulsants Phase 2
18 Antimanic Agents Phase 2
19 Central Nervous System Depressants Phase 2
20 Hypolipidemic Agents Phase 2
21 Lipid Regulating Agents Phase 2
22 Antimetabolites Phase 2
23
Atorvastatin Approved 134523-00-5 60823
24
Hydroxychloroquine Approved 118-42-3 3652
25 Anticholesteremic Agents
26 Hydroxymethylglutaryl-CoA Reductase Inhibitors
27 Antiparasitic Agents
28 Antiprotozoal Agents
29 Antirheumatic Agents
30 Antimalarials

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography: A Randomized Trial Completed NCT00830193 Phase 2, Phase 3 N-acetylcysteine;D5W Placebo
2 A Phase II Pilot Study to Explore Treatment With Sodium Valproate in Adults With McArdle Disease (Glycogen Storage Disorder Type V, GSDV) Completed NCT03112889 Phase 2 Sodium Valproate
3 Evaluation of the Effect of Bezafibrate on Muscle Metabolism During Exercise in Patients With CPTII and VLCAD Deficiency Completed NCT00983788 Phase 2 Bezafibrate
4 Triheptanoin's Effect on Fatty Acid Oxidation and Exercise Tolerance in Patients With Debrancher Deficiency, Glycogenin-1 Deficiency and Phosphofructoinase Deficiency at Rest and During Exercise. A Randomized, Double-blind, Placebo-controlled, Cross-over Study Recruiting NCT03642860 Phase 2 Triheptanoin;Placebo Oil
5 Near Infrared Spectroscopy for Determination of Tissue Oxygenation in Patients Undergoing Robotic Assisted Laparoscopic Surgery in the Trendelenburg Position - A Feasibility Study Unknown status NCT02829242
6 Incidence of Rhabdomyolysis Among Pediatric and Adolescent Patients Admitted for Jimsonweed (Datura Stramonium) Ingestions Completed NCT00592657
7 Biomarker for Duchenne Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL Recruiting NCT02994030
8 The Effect of Seven-Day Atorvastatin Administration on Emotional Processing, Reward Processing, and Inflammation in Healthy Volunteers Recruiting NCT03966859 Atorvastatin 20mg
9 Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency Not yet recruiting NCT04007562 Hydroxychloroquine Sulfate

Search NIH Clinical Center for Myoglobinuria

Cochrane evidence based reviews: myoglobinuria

Sources

Genetic Tests for Myoglobinuria

About this section
Sources

Anatomical Context for Myoglobinuria

About this section

MalaCards organs/tissues related to Myoglobinuria:

40
Kidney, Testes, Liver, Skeletal Muscle, Spinal Cord, Brain, Heart
Sources

Publications for Myoglobinuria

About this section

Articles related to Myoglobinuria:

(show top 50) (show all 1407)
# Title Authors PMID Year
1
Oxygen embolism after hydrogen peroxide irrigation during hip arthroscopy: a case report. 61
32000742 2020
2
Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease. 61
31511858 2020
3
Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria. 61
31865445 2019
4
Analysis of the Safety and Efficacy of the Endovascular Treatment for Acute Limb Ischemia with Percutaneous Pharmacomechanical Thrombectomy Compared with Catheter-Directed Thrombolysis. 61
31863953 2019
5
Histopathological kidney changes and myoglobinuria in neotropical non-human primates attacked by dogs, Brazil. 61
31885097 2019
6
Value and Use of Urinalysis for Myoglobinuria. 61
31116043 2019
7
Cytosorb for Management of Acute Kidney Injury due to Rhabdomyolysis in a Child. 61
31729332 2019
8
Current and emerging therapies in Becker muscular dystrophy (BMD). 61
31788661 2019
9
Rhabdomyolysis and myoglobinuria following bisphosphonate infusion in patients with Duchenne muscular dystrophy. 61
31213343 2019
10
Neuron-specific knockdown of Drosophila HADHB induces a shortened lifespan, deficient locomotive ability, abnormal motor neuron terminal morphology and learning disability. 61
30953623 2019
11
Muscle soreness and rhabdomyolysis. 61
31238673 2019
12
A voltage-based analysis of fluid delivery and outcomes in burn patients with electrical injuries over a 6-year period. 61
30935702 2019
13
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency. 61
29493437 2019
14
Alcohol Withdrawal Mimicking Neuroleptic Malignant Syndrome. 61
31338272 2019
15
[Carnitin-Palmitoyl Transferase type 2 deficiency: a rare cause of acute renal failure due to rhabdomyolysis]. 61
30983179 2019
16
Update: Exertional rhabdomyolysis, active component, U.S. Armed Forces, 2014-2018. 61
31026174 2019
17
Presumed Malignant Hyperthermia Treated During Cardiopulmonary Bypass in a Pediatric Patient Undergoing Aortic Valve Replacement: A Case Report. 61
30299295 2019
18
Purple urine bag syndrome. 61
30917642 2019
19
Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review. 61
31089417 2019
20
Unrecognized High Occurrence of Genetically Confirmed Hereditary Carnitine Palmitoyltransferase II Deficiency in an Austrian Family Points to the Ongoing Underdiagnosis of the Disease. 61
31191612 2019
21
A systematic review on the definition of rhabdomyolysis. 61
30617905 2019
22
A Hemizygous Deletion Within the PGK1 Gene in Males with PGK1 Deficiency. 61
30570712 2019
23
Combined HIIT and Resistance Training in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: A Case Report. 61
31191348 2019
24
An unusual case of gross myoglobinuria in a child following Russell's viper (Daboia russelii) envenomation. 61
30448288 2019
25
To absorb fat - supersize my lipid droplets. 61
30507609 2019
26
Late and Severe Myopathy in a Patient With Glycogenosis VII Worsened by Cyclosporine and Amiodarone. 61
30792690 2019
27
Novel heterozygous mutations in the PGAM2 gene with negative exercise testing. 61
30310767 2018
28
Rhabdomyolysis observed at forensic autopsy: a series of 52 cases. 61
30056625 2018
29
Acute kidney injury secondary to traumatic rhabdomyolysis in a dog. 61
30222253 2018
30
Propofol infusion-like syndrome in a dog. 61
30410181 2018
31
Acute Limb Ischemia. 61
30243449 2018
32
Myoglobinuria in two patients with Duchenne muscular dystrophy after treatment with zoledronate: a case-report and call for caution. 61
30217487 2018
33
Electrical burn injury: a comparison of outcomes of high voltage versus low voltage injury in an Indian scenario. 61
30863247 2018
34
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiency. 61
30111548 2018
35
Biblical myoglobinuria. 61
30133983 2018
36
Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis. 61
30042104 2018
37
Outcome of Benign Acute Childhood Myositis: The Experience of 2 Large Tertiary Care Pediatric Hospitals. 61
29851916 2018
38
Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt. 61
29744303 2018
39
TREATMENT OF SUSPECTED EXERTIONAL MYOPATHY USING DANTROLENE IN A COYOTE ( CANIS LATRANS). 61
29900791 2018
40
McArdle's disease: A differential diagnosis of idiopathic toe walking. 61
29881221 2018
41
Electrical Burns and Their Treatment in a Tertiary Hospital in Albania. 61
29875855 2018
42
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury. 61
29731937 2018
43
Exercise-Induced Abdominal Wall Muscle Injury Resulting in Rhabdomyolysis and Mimicking an Acute Abdomen. 61
29420397 2018
44
Case 251: Nontraumatic Drug-associated Rhabdomyolysis of Head and Neck Muscles. 61
29461948 2018
45
Local morbidity from red-bellied black snake (Pseudechis porphyriacus, Elapidae) envenoming: Two cases and a brief review of management. 61
29269114 2018
46
Acute polyneuromyopathy with respiratory failure secondary to monensin intoxication in a dog. 61
29210488 2018
47
Mutations in GMPPB Presenting with Pseudometabolic Myopathy. 61
28456886 2018
48
Nontraumatic Exertional Rhabdomyolysis Leading to Acute Kidney Injury in a Sickle Trait Positive Individual on Renal Biopsy. 61
29850311 2018
49
TANGO2-Related Metabolic Encephalopathy and Arrhythmias 61
29369572 2018
50
Exercise-induced acute renal failure in a trainee cyclist without hypouricemia: Successful athletic career post-treatment. 61
29264080 2017
Sources

Variations for Myoglobinuria

About this section
Sources

Expression for Myoglobinuria

About this section
Search GEO for disease gene expression data for Myoglobinuria.
Sources

Pathways for Myoglobinuria

About this section

Pathways related to Myoglobinuria according to GeneCards Suite gene sharing:

(show all 15)
# Super pathways Score Top Affiliating Genes
1
Metabolism 65
Show member pathways
 13.56 PYGM PIK3C2A PHKA1 PGK1 PGAM2 PGAM1
2
Glycosaminoglycan metabolism 65
Show member pathways
 12.66 PYGM PHKA1 PGK1 PGAM2 PGAM1 PFKM
3
Glucose metabolism 65
Show member pathways
 12.44 PYGM PHKA1 PGK1 PGAM2 PGAM1 PFKM
4
Glucose / Energy Metabolism 4
12.34 PGAM1 MB LPIN1 LDHA GAPDH
5
Fatty Acyl-CoA Biosynthesis 65
Show member pathways
 12.29 LPIN1 HADH CPT2 ACADVL
6
Carbon metabolism 36
Show member pathways
 12.13 PGK1 PGAM2 PGAM1 PFKM GPT GAPDH
7
HIF-1 signaling pathway 36
11.77 PGK1 PFKM LDHA GAPDH
8
Citrate cycle (TCA cycle) 36
Show member pathways
 11.74 PGK1 PGAM2 PFKM
9
Glucagon signaling pathway 36
11.66 PYGM PHKA1 PGAM2 PGAM1 PFKM LDHA
10
Cardiac muscle contraction 36
11.63 MT-CYB MT-CO3 MT-CO1
11
Validated targets of C-MYC transcriptional activation 1
11.59 PFKM LDHA GAPDH
12
Central carbon metabolism in cancer 36
11.54 PGAM2 PGAM1 PFKM LDHA
13
Mitochondrial LC-Fatty Acid Beta-Oxidation 1
Show member pathways
 11.38 HADH CPT2 ACADVL
14
Effects of Nitric Oxide 1
10.4 MT-CO1 MB
15
Cori Cycle 1
10.23 PGK1 PGAM1 LDHA GPT GAPDH
Sources

GO Terms for Myoglobinuria

About this section

Cellular components related to Myoglobinuria according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.61 PYGM PIK3C2A PGK1 PGAM2 PGAM1 MB
2 mitochondrial inner membrane GO:0005743 9.55 MT-CYB MT-CO3 MT-CO1 CPT2 ACADVL
3 cytosol GO:0005829 9.5 PYGM PIK3C2A PHKA1 PGK1 PGAM2 PGAM1
4 mitochondrial respiratory chain complex III GO:0005750 9.32 MT-CYB MT-CO1
5 respiratory chain complex IV GO:0045277 9.26 MT-CO3 MT-CO1

Biological processes related to Myoglobinuria according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 oxidation-reduction process GO:0055114 9.95 MT-CYB MT-CO1 LDHA HADH GAPDH ACADVL
2 fatty acid metabolic process GO:0006631 9.71 LPIN1 HADH CPT2 ACADVL
3 positive regulation of cold-induced thermogenesis GO:0120162 9.69 LPIN1 HADH CPT2
4 response to hormone GO:0009725 9.63 MT-CYB MB HADH
5 muscle cell cellular homeostasis GO:0046716 9.56 PFKM DMD
6 mitochondrial electron transport, cytochrome c to oxygen GO:0006123 9.55 MT-CO3 MT-CO1
7 respiratory electron transport chain GO:0022904 9.54 MT-CYB MT-CO3
8 fatty acid beta-oxidation GO:0006635 9.54 HADH CPT2 ACADVL
9 response to copper ion GO:0046688 9.52 MT-CYB MT-CO1
10 fatty acid catabolic process GO:0009062 9.49 LPIN1 ACADVL
11 gluconeogenesis GO:0006094 9.46 PGK1 PGAM2 PGAM1 GAPDH
12 response to mercury ion GO:0046689 9.43 PGAM2 MT-CYB
13 glycogen catabolic process GO:0005980 9.43 PYGM PHKA1 PFKM
14 canonical glycolysis GO:0061621 9.35 PGK1 PGAM2 PGAM1 PFKM GAPDH
15 electron transport coupled proton transport GO:0015990 9.32 MT-CYB MT-CO1
16 glycolytic process GO:0006096 9.1 PGK1 PGAM2 PGAM1 PFKM LDHA GAPDH

Molecular functions related to Myoglobinuria according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intramolecular transferase activity, phosphotransferases GO:0016868 9.26 PGAM2 PGAM1
2 phosphoglycerate mutase activity GO:0004619 9.16 PGAM2 PGAM1
3 oxidoreductase activity GO:0016491 9.1 MT-CYB MT-CO1 LDHA HADH GAPDH ACADVL
4 bisphosphoglycerate mutase activity GO:0004082 8.96 PGAM2 PGAM1
Sources

Sources for Myoglobinuria

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....